2015
DOI: 10.1002/humu.22824
|View full text |Cite
|
Sign up to set email alerts
|

Mutations of the ImprintedCDKN1CGene as a Cause of the Overgrowth Beckwith-Wiedemann Syndrome: Clinical Spectrum and Functional Characterization

Abstract: Beckwith-Wiedemann syndrome (BWS) is an imprinting disorder associating macroglossia, abdominal wall defects, visceromegaly, and a high risk of childhood tumor. Molecular anomalies are mostly epigenetic; however, mutations of CDKN1C are implicated in 8% of cases, including both sporadic and familial forms. We aimed to describe the phenotype of BWS patients with CDKN1C mutations and develop a functional test for CDKN1C mutations. For each propositus, we sequenced the three exons and intron-exon boundaries of CD… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
81
0
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 74 publications
(85 citation statements)
references
References 35 publications
3
81
0
1
Order By: Relevance
“…Herein, we investigated whether the development of BWS, a disease whose aetiology has been attributed so far to the deregulation of CDK activity due to loss of p57 function, could be caused, at least in part, by the loss of CDK‐independent roles of p57, as suggested by the pattern of p57 point mutations observed in 8% of BWS patients and that occur mostly outside of the cyclin–CDK inhibitory region . Our studies provide clear genetic evidence for the importance of p57 CDK‐independent functions during embryonic development and in BWS pathogenesis.…”
Section: Discussionmentioning
confidence: 92%
“…Herein, we investigated whether the development of BWS, a disease whose aetiology has been attributed so far to the deregulation of CDK activity due to loss of p57 function, could be caused, at least in part, by the loss of CDK‐independent roles of p57, as suggested by the pattern of p57 point mutations observed in 8% of BWS patients and that occur mostly outside of the cyclin–CDK inhibitory region . Our studies provide clear genetic evidence for the importance of p57 CDK‐independent functions during embryonic development and in BWS pathogenesis.…”
Section: Discussionmentioning
confidence: 92%
“…Loss of function mutations of maternally expressed CDKN1C leads to BWS,11 whereas a gain of function mutation of this gene has been described in a family with SRS 12. Loss of function mutations of the paternally expressed IGF2 gene and genes which are upstream regulators of IGF2 such as HMGA2 or PLAG1 have also been described 13–16.…”
Section: Introductionmentioning
confidence: 99%
“…Brioude et al. recently reviewed the phenotype of 50 patients and seven fetuses with CDKN1C mutation and reported four tumors: neuroblastoma, ganglioneuroblastoma, melanoma, and acute lymphoid leukemia . To the best of our knowledge, this is a novel tumor (JGCT) in a patient with BWS.…”
Section: Discussionmentioning
confidence: 98%